Skip to main content
Caplight Logo









NapaJen Pharma, Inc.

NapaJen Pharma, Inc.

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.napajen.com/en/

Last Round

Series C

Dec 25, 2018

Total Funding Raised

$33.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NapaJen Pharma, Inc. is a drug discovery company that develops oligonucleotide therapeutics for immune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oligonucleotide drug deliverydrug delivery systemDectin-1 targetingsiRNA deliverytargeted drug deliveryimmunotherapygene therapy deliverynucleic acid therapiesRNAi therapeuticsgene silencingschizophyllanGraft-versus-Host DiseaseGvHDDDSantigen-presenting cellsbiotech partnershipsclinical-stage biopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NapaJen Pharma, Inc. Comparables

Compare NapaJen Pharma, Inc. with similar companies based on industry and business-model similarity.

NapaJen Pharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phio Pharmaceuticals Corp.
73%
MiNA Therapeutics
70%
Arrowhead Pharmaceuticals
64%

NapaJen Pharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 25, 2018
Series BDec 7, 2016
Series AFeb 3, 2014

NapaJen Pharma, Inc. Investors

Notable investors and investment history

NapaJen Pharma, Inc. investors
InvestorRounds
Mitsui Global InvestmentSeries B, Series C, Series A
Mizuho CapitalSeries B, Series A
Nissay CapitalSeries B
INCJ, Ltd.Series B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 316% MoM, from 252 to 1K.

  • Apr 17, 2026

    Monthly visitors increased 400% MoM.

NapaJen Pharma, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NapaJen Pharma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NapaJen Pharma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range2
Year Founded2004
Last FundingDec 25, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?